These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

623 related articles for article (PubMed ID: 16449303)

  • 1. Pathogenic role of Fgf23 in Hyp mice.
    Liu S; Zhou J; Tang W; Jiang X; Rowe DW; Quarles LD
    Am J Physiol Endocrinol Metab; 2006 Jul; 291(1):E38-49. PubMed ID: 16449303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct roles for intrinsic osteocyte abnormalities and systemic factors in regulation of FGF23 and bone mineralization in Hyp mice.
    Liu S; Tang W; Zhou J; Vierthaler L; Quarles LD
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1636-44. PubMed ID: 17848631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant Phex function in osteoblasts and osteocytes alone underlies murine X-linked hypophosphatemia.
    Yuan B; Takaiwa M; Clemens TL; Feng JQ; Kumar R; Rowe PS; Xie Y; Drezner MK
    J Clin Invest; 2008 Feb; 118(2):722-34. PubMed ID: 18172553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone proteins PHEX and DMP1 regulate fibroblastic growth factor Fgf23 expression in osteocytes through a common pathway involving FGF receptor (FGFR) signaling.
    Martin A; Liu S; David V; Li H; Karydis A; Feng JQ; Quarles LD
    FASEB J; 2011 Aug; 25(8):2551-62. PubMed ID: 21507898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of the DMP1 C-terminal fragment stimulates FGF23 and exacerbates the hypophosphatemic rickets phenotype in Hyp mice.
    Martin A; David V; Li H; Dai B; Feng JQ; Quarles LD
    Mol Endocrinol; 2012 Nov; 26(11):1883-95. PubMed ID: 22930691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Phex mutation in a murine model of X-linked hypophosphatemia alters phosphate responsiveness of bone cells.
    Ichikawa S; Austin AM; Gray AK; Econs MJ
    J Bone Miner Res; 2012 Feb; 27(2):453-60. PubMed ID: 22006791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylated acidic serine-aspartate-rich MEPE-associated motif peptide from matrix extracellular phosphoglycoprotein inhibits phosphate regulating gene with homologies to endopeptidases on the X-chromosome enzyme activity.
    Liu S; Rowe PS; Vierthaler L; Zhou J; Quarles LD
    J Endocrinol; 2007 Jan; 192(1):261-7. PubMed ID: 17210763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteomalacia in hyp mice is associated with abnormal phex expression and with altered bone matrix protein expression and deposition.
    Miao D; Bai X; Panda D; McKee M; Karaplis A; Goltzman D
    Endocrinology; 2001 Feb; 142(2):926-39. PubMed ID: 11159866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complex intrinsic abnormalities in osteoblast lineage cells of X-linked hypophosphatemia: Analysis of human iPS cell models generated by CRISPR/Cas9-mediated gene ablation.
    Nakanishi T; Yamazaki M; Tachikawa K; Ueta A; Kawai M; Ozono K; Michigami T
    Bone; 2024 Apr; 181():117044. PubMed ID: 38331306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization.
    Quarles LD
    Am J Physiol Endocrinol Metab; 2003 Jul; 285(1):E1-9. PubMed ID: 12791601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The wrickkened pathways of FGF23, MEPE and PHEX.
    Rowe PS
    Crit Rev Oral Biol Med; 2004 Sep; 15(5):264-81. PubMed ID: 15470265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excessive Osteocytic Fgf23 Secretion Contributes to Pyrophosphate Accumulation and Mineralization Defect in Hyp Mice.
    Murali SK; Andrukhova O; Clinkenbeard EL; White KE; Erben RG
    PLoS Biol; 2016 Apr; 14(4):e1002427. PubMed ID: 27035636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteocyte-specific deletion of Fgfr1 suppresses FGF23.
    Xiao Z; Huang J; Cao L; Liang Y; Han X; Quarles LD
    PLoS One; 2014; 9(8):e104154. PubMed ID: 25089825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FGF23-induced hypophosphatemia persists in Hyp mice deficient in the WNT coreceptor Lrp6.
    Uchihashi K; Nakatani T; Goetz R; Mohammadi M; He X; Razzaque MS
    Contrib Nephrol; 2013; 180():124-37. PubMed ID: 23652555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX.
    Liu S; Guo R; Simpson LG; Xiao ZS; Burnham CE; Quarles LD
    J Biol Chem; 2003 Sep; 278(39):37419-26. PubMed ID: 12874285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of bone-renal mineral and energy metabolism: the PHEX, FGF23, DMP1, MEPE ASARM pathway.
    Rowe PS
    Crit Rev Eukaryot Gene Expr; 2012; 22(1):61-86. PubMed ID: 22339660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenic role of Fgf23 in Dmp1-null mice.
    Liu S; Zhou J; Tang W; Menard R; Feng JQ; Quarles LD
    Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E254-61. PubMed ID: 18559986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel Phex mutation in a new mouse model of hypophosphatemic rickets.
    Owen C; Chen F; Flenniken AM; Osborne LR; Ichikawa S; Adamson SL; Rossant J; Aubin JE
    J Cell Biochem; 2012 Jul; 113(7):2432-41. PubMed ID: 22573557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulated gene expression in the primary osteoblasts and osteocytes isolated from hypophosphatemic Hyp mice.
    Miyagawa K; Yamazaki M; Kawai M; Nishino J; Koshimizu T; Ohata Y; Tachikawa K; Mikuni-Takagaki Y; Kogo M; Ozono K; Michigami T
    PLoS One; 2014; 9(4):e93840. PubMed ID: 24710520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel regulators of Fgf23 expression and mineralization in Hyp bone.
    Liu S; Tang W; Fang J; Ren J; Li H; Xiao Z; Quarles LD
    Mol Endocrinol; 2009 Sep; 23(9):1505-18. PubMed ID: 19556340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.